nach oben

Erschienen in:

01.11.2008 | Original Article

Profile of Th17 cytokines (IL-17, TGF-β, IL-6) and Th1 cytokine (IFN-γ) in patients with immune thrombocytopenic purpura

verfasst von: Daoxin Ma, Xiaojuan Zhu, Ping Zhao, Chunhong Zhao, Xiaofang Li, Yuanyuan Zhu, Lizhen Li, Jianzhi Sun, Jun Peng, Chunyan Ji, Ming Hou

Erschienen in: Annals of Hematology | Ausgabe 11/2008

Einloggen, um Zugang zu erhalten

Abstract

The data on polarization of the immune system towards T helper 1 (Th1) or T helper 2 (Th2) cells in immune thrombocytopenic purpura (ITP) are limited and contradictory. Th17 characterized by the production of Interleukin 17 (IL-17) has been shown to play a crucial part in the induction of autoimmune diseases. To further investigate the role of Th cytokines in the pathogenesis of ITP, we measured the plasma concentration of three Th17-associated cytokines [IL-17, transforming growth factor-ß (TGF-ß), IL-6] and Th1 cytokine interferon-γ (IFN-γ) in ITP patients, and evaluated their clinical relevance. The concentration of IL-17, TGF-ß, IL-6, and IFN-γ in plasma specimens from 29 adults with chronic ITP and 38 controls was analyzed by enzyme-linked immunosorbent assay method. No significant differences of Th17 cytokines (IL-17, TGF-ß, and IL-6) and Th1 cytokine (IFN-γ) concentration were observed between patients with active ITP and the control group. And the IFN-γ/IL-17 ratio representing Th1/Th17 cytokine profile was not significantly different between ITP patients and control, either. However, significantly positive correlation between IL-6 and IFN-γ in ITP patients was observed (r = 0.48, P = 0.01). Among the ITP patients, Plasma IL-17 levels in male were marginally higher than those in female, while similar for TGF-ß, IL-6 or IFN-γ. There was a significantly positive correlation between age and IL-6 concentration in ITP patients (r = 0.56, P = 0.0002), while no statistical significance between age and the other three cytokines. No significant correlation between cytokine concentrations and platelets or megakaryocytes number was found in ITP patients. In summary, ITP may not be associated with changes of plasma Th17 and Th1 cytokine concentrations relative to control population.

Aggarwal S, Ghilardi N, Xie MH, de Sauvage FJ, Gurney AL (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910–1914 doi:10.1074/jbc.M207577200 PubMedCrossRef

Andersson PO, Stockelberg D, Jacobsson S, Wadenvik H (2000) A transforming growth factor-beta1-mediated bystander immune suppression could be associated with remission of chronic idiopathic thrombocytopenic purpura. Ann Hematol 79:507–513 doi:10.1007/s002770000177 PubMedCrossRef

Butrimiene I, Jarmalaite S, Ranceva J, Venalis A, Jasiuleviciute L, Zvirbliene A (2004) Different cytokine profiles in patients with chronic and acute reactive arthritis. Rheumatology (Oxford) 43:1300–1304 doi:10.1093/rheumatology/keh323 CrossRef

Cines DB, Blanchette VS (2002) Immune thrombocytopenic purpura. N Engl J Med 346:995–1008 doi:10.1056/NEJMra010501 PubMedCrossRef

Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B et al (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421:744–748 doi:10.1038/nature01355 PubMedCrossRef

Elson CO, Cong Y, Brandwein S, Weaver CT, McCabe RP, Mähler M et al (1998) Experimental models to study molecular mechanisms underlying intestinal inflammation. Ann N.Y. Acad Sci 859:85–95 doi:10.1111/j.1749-6632.1998.tb11113.x PubMedCrossRef

George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ et al (1996) Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 88:3–40PubMed

Harrington LE, Hatton RD, Mangan PR, Turner H, Murphy TL, Murphy KM et al (2005) Interleukin 17-producing CD4(+) effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123–1132 doi:10.1038/ni1254 PubMedCrossRef

Hoffman R, Zaknoen S, Yang HH, Bruno E, LoBuglio AF, Arrowsmith JB et al (1985) An antibody cytotoxic to megakaryocyte progenitor cells in a patient with immune thrombocytopenic purpura. N Engl J Med 312:1170–1174PubMed

10.

Karlsson FA, Berne C, Björk E, Kullin M, Li Z, Ma JY et al (2000) Beta-cell activity and destruction in type 1 diabetes. Ups J Med Sci 105:85–95PubMed

11.

Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, Iwakura Y, Sakaguchi N, Sakaguchi S (2007) T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17⁺ Th cells that cause autoimmune arthritis. J Exp Med 204:41–47 doi:10.1084/jem.20062259 PubMedCrossRef

12.

Kolls JK, Linden A (2004) Interleukin-17 family members and inflammation. Immunity 21:467–476 doi:10.1016/j.immuni.2004.08.018 PubMedCrossRef

13.

Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, Sedgwick JD et al (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201:233–240 doi:10.1084/jem.20041257 PubMedCrossRef

14.

McMillan R, Luiken GA, Levy R, Yelenosky R, Longmire RL (1978) Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA 239:2460–2462 doi:10.1001/jama.239.23.2460 PubMedCrossRef

15.

Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138–146 doi:10.1016/0167-5699(96)80606-2 PubMedCrossRef

16.

Murphy CA, Langrish CL, Chen Y, Blumenschein W, McClanahan T, Kastelein RA et al (2003) Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 198:1951–1957 doi:10.1084/jem.20030896 PubMedCrossRef

17.

Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, Homma I et al (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17:375–387 doi:10.1016/S1074-7613(02)00391-6 PubMedCrossRef

18.

Nomura S, Yanabu M, Kido H, Lan XG, Ichiyoshi H, Katsura K et al (1995) Significance of cytokines and CD68-positive microparticles in immune thrombocytopenic purpura. Eur J Haematol 55:49–56PubMedCrossRef

19.

Ogawara H, Handa H, Morita K, Hayakawa M, Kojima J, Amagai H et al (2003) High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol 71:283–288 doi:10.1034/j.1600-0609.2003.00138.x PubMedCrossRef

20.

Panitsas FP, Theodoropoulou M, Kouraklis A, Karakantza M, Theodorou GL, Zoumbos NC et al (2004) Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response. Blood 103:2645–2647 doi:10.1182/blood-2003-07-2268 PubMedCrossRef

21.

Park H, Li Z, Yang XO, Chang SH, Nurieva R, Wang YH et al (2005) A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 6:1133–1141 doi:10.1038/ni1261 PubMedCrossRef

22.

Stahl CP, Zucker-Franklin D, McDonald TP (1986) Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood 67:421–428PubMed

23.

Stasi R, Del Poeta G, Stipa E, Evangelista ML, Trawinska MM, Cooper N et al (2007) Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura. Blood 110:2924–2930 doi:10.1182/blood-2007-02-068999 PubMedCrossRef

24.

Vainchenker W, Deschamps JF, Bastin JM, Guichard J, Titeux M, Breton-Gorius J et al (1982) Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in vivo cells from normal and leukemia patients. Blood 59:514–521PubMed

25.

Wang HL (2003) Clinical hematologic analysis. In: Cheng WB, Wang YC (eds) Diagnostics, 5th Ed. The People’s Health, Peking, pp 301–302 (In Chinese)

26.

Wang T, Zhao H, Ren H, Guo J, Xu M, Yang R et al (2005) Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica 90:914–923PubMed

27.

Webber NP, Mascarenhas JO, Crow MK, Bussel J, Schattner EJ (2001) Functional properties of lymphocytes in idiopathic thrombocytopenic purpura. Hum Immunol 62:1346–1355 doi:10.1016/S0198-8859(01)00348-2 PubMedCrossRef

28.

Yen D, Cheung J, Scheerens H, Poulet F, McClanahan T, McKenzie B et al (2006) IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 116:1310–1316 doi:10.1172/JCI21404 PubMedCrossRef

29.

Yoshimura C, Nomura S, Nagahama M, Ozaki Y, Kagawa H, Fukuhara S (2000) Plasma-soluble Fas (APO-1, CD95) and soluble Fas ligand in immune thrombocytopenic purpura. Eur J Haematol 64:219–224 doi:10.1034/j.1600-0609.2000.9o096.x PubMedCrossRef

30.

Zhang L, Li H, Zhao H, Ji X, Yang R (2003) Hepatitis C virus-related adult chronic idiopathic thrombocytopenic purpura: experience from a single Chinese center. Eur J Haematol 70:196–197 doi:10.1034/j.1600-0609.2003.00032.x PubMedCrossRef

31.

Chen Z, Tato CM, Muul L, Laurence A, O'Shea JJ (2007) Distinct regulation of interleukin-17 in human T helper lymphocytes. Arthritis Rheum 56:2936–2946 doi:10.1002/art.22866 PubMedCrossRef

32.

Zhou B, Zhao H, Yang RC, Han ZC (2005) Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol 54:107–116 doi:10.1016/j.critrevonc.2004.12.004 PubMedCrossRef

Titel: Profile of Th17 cytokines (IL-17, TGF-β, IL-6) and Th1 cytokine (IFN-γ) in patients with immune thrombocytopenic purpura
verfasst von: Daoxin Ma
Xiaojuan Zhu
Ping Zhao
Chunhong Zhao
Xiaofang Li
Yuanyuan Zhu
Lizhen Li
Jianzhi Sun
Jun Peng
Chunyan Ji
Ming Hou
Publikationsdatum: 01.11.2008
Verlag: Springer-Verlag
Erschienen in: Annals of Hematology / Ausgabe 11/2008
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI: https://doi.org/10.1007/s00277-008-0535-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Profile of Th17 cytokines (IL-17, TGF-β, IL-6) and Th1 cytokine (IFN-γ) in patients with immune thrombocytopenic purpura

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

Update Innere Medizin

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2008

Resolution of left and right ventricular thrombosis secondary to hypereosinophilic syndrome (lymphoproliferative variant) with reduced intensity conditioning allogenic stem cell transplantation

Feasibility, cost-effectiveness and patients’ acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic

Farnesyl transferase inhibitor (lonafarnib) in patients with myelodysplastic syndrome or secondary acute myeloid leukaemia: a phase II study

Effective screening for double heterozygosity of Hb E/α0-thalassemia

Leopard spot retinopathy: an early clinical marker of leukaemia recurrence?

Historical review. The light and shadow of Paul Kaznelson: his life and contribution to hematology

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Costims – das nächste heiße Ding in der Krebstherapie?

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

Update Innere Medizin